Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

482
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
482
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants01:18

Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants

2.7K
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
2.7K
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

2.6K
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
2.6K
Venous Thrombosis IV: Nursing Management01:30

Venous Thrombosis IV: Nursing Management

413
Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
413
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

746
Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
746
Cardiovascular Drugs: Classification based on Therapeutic Indications01:18

Cardiovascular Drugs: Classification based on Therapeutic Indications

4.2K
Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However,...
4.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Effect of routinely tailoring anti-hypertensive therapy to hemodynamic profile in primary care.

The American journal of medicine·2026
Same author

Health Resources and Services Administration and Veterans Affairs Funding Intersections Expand Graduate Medical Education Training Opportunities in Rural and Underserved Areas.

The Journal of rural health : official journal of the American Rural Health Association and the National Rural Health Care Association·2026
Same author

The Evolving Role of Critical Access Hospitals in Rural Physician Training.

JAMA health forum·2025
Same author

Comparing Indian Health Service Sites to Rural Physician Teaching Hospitals.

JAMA internal medicine·2025
Same author

Evaluating Teaching Health Center Planning and Development: Unlocking and Sustaining the Full Potential of the Teaching Health Center Program.

Journal of graduate medical education·2025
Same author

Faculty Development in New and Emerging Rural Residency Programs.

Journal of graduate medical education·2025

Related Experiment Video

Updated: Apr 26, 2026

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation
23:33

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation

Published on: February 28, 2012

84.2K

Anticoagulation: indications and risk classification schemes.

Emily M Hawes1, Anthony J Viera2

  • 1UNC Chapel Hill Department of Family Medicine, 590 Manning Drive CB 7595, Chapel Hill, NC 27599, EHawes@unch.unc.edu.

FP Essentials
|July 18, 2014
PubMed
Summary

Anticoagulation therapy is crucial for preventing blood clots in conditions like venous thromboembolism (VTE) and stroke. Risk assessment scores guide treatment decisions for surgical and non-surgical patients, ensuring appropriate anticoagulation management.

More Related Videos

Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function
10:28

Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function

Published on: March 15, 2022

7.7K
Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
28:13

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation

Published on: February 26, 2013

34.6K

Related Experiment Videos

Last Updated: Apr 26, 2026

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation
23:33

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation

Published on: February 28, 2012

84.2K
Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function
10:28

Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function

Published on: March 15, 2022

7.7K
Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
28:13

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation

Published on: February 26, 2013

34.6K

Area of Science:

  • Cardiology
  • Hematology
  • Vascular Medicine

Background:

  • Anticoagulation is a cornerstone in managing conditions such as venous thromboembolism (VTE) and ischemic stroke.
  • It plays a vital role in preventing recurrent thrombosis and managing risks associated with surgical procedures.
  • Nonsurgical hospitalized patients with immobility or other risk factors also benefit from anticoagulation therapy.

Purpose of the Study:

  • To outline the indications and strategies for anticoagulation in various medical and surgical scenarios.
  • To highlight the use of risk assessment models in guiding anticoagulation therapy decisions.
  • To define the duration of anticoagulation based on specific patient conditions and risk factors.

Main Methods:

  • Review of established guidelines and risk assessment tools for anticoagulation.
  • Application of scoring systems like Caprini Risk Assessment Model and CHADS2 score for risk stratification.
  • Analysis of patient populations including those with VTE, atrial fibrillation, post-surgery, and acute coronary syndrome.

Main Results:

  • Anticoagulation is indicated for VTE prevention, stroke prevention in atrial fibrillation, and post-major orthopedic surgery.
  • Risk scores (Caprini, CHADS2) aid in tailoring anticoagulation for surgical and non-surgical patients.
  • Lifelong anticoagulation is recommended for patients with mechanical heart valves.

Conclusions:

  • Anticoagulation therapy is essential across a spectrum of conditions, from VTE and stroke to post-operative care.
  • Risk stratification models are critical for personalized and effective anticoagulation management.
  • Treatment duration varies, with lifelong therapy necessary for mechanical heart valves.